TY - JOUR T1 - Detailed Overview of the Buildout and Integration of an Automated High-Throughput CLIA Laboratory for SARS-CoV-2 Testing on a Large Urban Campus JF - medRxiv DO - 10.1101/2021.09.13.21263214 SP - 2021.09.13.21263214 AU - Lena Landaverde AU - David McIntyre AU - James Robson AU - Dany Fu AU - Luis Ortiz AU - Rita Chen AU - Samuel M.D. Oliveira AU - Andy Fan AU - Amy Barrett AU - Stephen P. Burgay AU - Stephen Choate AU - David Corbett AU - Lynn Doucette-Stamm AU - Kevin Gonzales AU - Davidson H. Hamer AU - Lilly Huang AU - Shari Huval AU - Christopher Knight AU - Diane Lindquist AU - Kelly Lockard AU - Trevor L. Macdowell AU - Elizabeth Mauro AU - Colleen McGinty AU - Candice Miller AU - Maura Monahan AU - Randall Moore AU - Judy Platt AU - Jeffrey Roy AU - Tracey Schroeder AU - Dean R. Tolan AU - Ann Zaia AU - Robert A. Brown AU - Gloria Waters AU - Douglas Densmore AU - Catherine M. Klapperich Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/01/2021.09.13.21263214.abstract N2 - In 2019, the first cases of SARS-CoV-2 were detected in Wuhan, China, and by early 2020 the cases were identified in the United States. SARS-CoV-2 infections increased in the US causing many states to implement stay-at-home orders and additional safety precautions to mitigate potential outbreaks. As policies changed throughout the pandemic and restrictions lifted, there was an increase in demand for Covid-19 testing which was costly, difficult to obtain, or had long turn-around times. Some academic institutions, including Boston University, created an on-campus Covid-19 screening protocol as part of planning for the safe return of students, faculty, and staff to campus with the option for in-person classes. At BU, we stood up an automated high-throughput clinical testing lab with the capacity to run 45,000 individual tests weekly by fall of 2020, with a purpose-built clinical testing laboratory, a multiplexed RT-PCR test, robotic instrumentation, and trained CLIA certified staff. There were challenges to overcome, including the supply chain issues for PPE testing materials, and equipment that were in high demand. The Boston University Clinical Testing Laboratory was operational at the start of the fall 2020 academic year. The lab performed over 1 million SARS-CoV-2 RT-PCR tests during the 2020-2021 academic year.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was used for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:CLIA is the oversight body for clinical testing laboratories. We adhere to all CLIA requirements.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request. ER -